FDA Delays PMTA Review for Popular E-Cigarettes until 2023
In a court filing this week, the US Food and Drug Administration (FDA) stated that the review process for premarket tobacco product applications (PMTAs) for some of the most popular electronic cigarettes on the market may not be completed until December 31, 2023.
Earlier, at the 2022 Global Tobacco and Nicotine Forum (GTNF), Brian A. King, director of the Center for Tobacco Products (CTP) at the U.S. Food and Drug Administration (FDA), promised that the CTP would finish the remaining portion of 6.7 million applications by mid-2023. However, according to the latest information, the timeline for completing all application approvals will be delayed by six months.
The court initially set a deadline of September 9, 2021 for the completion of pre-market tobacco product applications (PMTAs) for electronic cigarettes. However, this deadline has now been exceeded by 16 months.
2FIRSTS will continue to follow this issue and report on it in the upcoming month as we engage in a dialogue with the FDA concerning the future of electronic cigarettes in the United States. Stay tuned for updates.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
